All Stories

  1. Short-Term Water- and Land-Based Exercise Training Comparably Improve Exercise Capacity and Vascular Function in Patients After a Recent Coronary Event: A Pilot Randomized Controlled Trial

    Article • Frontiers in Physiology, July 2019, Frontiers

    Mojca Bozic

  2. Intra- and inter- individual rivaroxaban concentrations and potential bleeding risk in patients with atrial fibrillation

    Article • European Journal of Clinical Pharmacology, May 2019, Springer Science + Business Media

    Mojca Bozic

  3. Lifestyle contributes to cardiovascular events in PAD patients more than genetics

    Article • VASA, May 2019, Hogrefe Publishing Group

    Mojca Bozic

  4. Endocan Is an Independent Predictor of Heart Failure-Related Mortality and Hospitalizations in Patients with Chronic Stable Heart Failure

    Article • Disease Markers, April 2019, Hindawi Publishing Corporation

    Mojca Bozic

  5. Advances in monitoring anticoagulant therapy

    Article • January 2019, Elsevier

    Mojca Bozic

  6. Late rebound of dabigatran levels after idarucizumab reversal in two patients with severe renal failure

    Article • European Journal of Anaesthesiology, June 2017, Wolters Kluwer Health

    Mojca Bozic

  7. Increased Coagulation and Decreased Fibrinolysis as Measured with Overall Hemostatic Potential Are Dependent on BMI and Not Associated with PCOS

    Article • Metabolic Syndrome and Related Disorders, May 2017, Mary Ann Liebert Inc

    Mojca Bozic

  8. Rotational thromboelastometry in ex vivo samples from routine clinical practice patients receiving dabigatran

    Article • Clinica Chimica Acta, March 2017, Elsevier

    Mojca Bozic

  9. Ticagrelor Versus Clopidogrel in Comatose Survivors of Out-of-Hospital Cardiac Arrest Undergoing Percutaneous Coronary Intervention and Hypothermia

    Article • Circulation, December 2016, Wolters Kluwer Health

    Mojca Bozic

  10. Diluted thrombin time reliably measures low to intermediate plasma dabigatran concentrations

    Article • Annals of Clinical Biochemistry International Journal of Laboratory Medicine, July 2016, SAGE Publications

    Mojca Bozic

  11. Development and preclinical pharmacokinetics of a novel subcutaneous thermoresponsive system for prolonged delivery of heparin

    Article • International Journal of Pharmaceutics, December 2015, Elsevier

    Mojca Bozic

  12. Dabigatran Concentration: Variability and Potential Bleeding Prediction In “Real-Life” Patients With Atrial Fibrillation

    Article • Basic & Clinical Pharmacology & Toxicology, June 2015, Wiley

    Mojca Bozic

  13. Ex vivo neutralization of unfractionated heparin for assessing overall haemostatic potential in patient plasma

    Article • Thrombosis Research, May 2015, Elsevier

    Mojca Bozic

  14. Platelet reactivity in comatose survivors of cardiac arrest undergoing percutaneous coronary intervention and hypothermia

    Article • EuroIntervention, April 2015, Europa Digital & Publishing

    Mojca Bozic

  15. C0372 Enhanced thrombin generation in women with history of oral contraception related venous thrombosis

    Article • Thrombosis Research, October 2012, Elsevier

    Mojca Bozic

  16. C0211 Activation and balance of coagulation in pregnant women treated with low-molecular weight heparin, administered in therapeutic or preventive dosage

    Article • Thrombosis Research, October 2012, Elsevier

    Mojca Bozic

  17. C0185 Can overall haemostasis potential (OHP) discriminate between patients who will suffer early restenosis after femoropopliteal percutaneous transluminal angioplasty (PTA) from those who will not?

    Article • Thrombosis Research, October 2012, Elsevier

    Mojca Bozic

  18. Nurr1 Haplotypes are Associated with Femoropopliteal Restenosis/Re-occlusion after Percutaneous Transluminal Angioplasty

    Article • European Journal of Vascular and Endovascular Surgery, March 2012, Elsevier

    Mojca Bozic

  19. Hyperhomocysteinemia and thrombophilia

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2010, De Gruyter

    Mojca Bozic

  20. The effect of pre-analytical variables on light transmittance aggregometry in citrated platelet-rich plasma from healthy subjects

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2010, De Gruyter

    Mojca Bozic

  21. Hemostasis Activation in Thrombophilic Subjects With or Without a History of Venous Thrombosis

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2008, SAGE Publications

    Mojca Bozic

  22. Determination of D-dimer by different quantitative assays - A harmonization exercise

    Article • Biochemia Medica, January 2008, Croatian Society for Medical Biochemistry and Laboratory Medicine

    Mojca Bozic

  23. Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia

    Article • Thrombosis Research, January 2007, Elsevier

    Mojca Bozic

  24. Evaluation of pre-analytical, demographic, behavioural and metabolic variables on fibrinolysis and haemostasis activation markers utilised to assess hypercoagulability

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2007, De Gruyter

    Mojca Bozic

  25. Major and Potential Prothrombotic Genotypes in Patients with Venous Thrombosis and in Healthy Subjects from Slovenia

    Article • Pathophysiology of Haemostasis and Thrombosis, January 2007, Karger Publishers

    Mojca Bozic

  26. Utility of PFA-100® closure time vs. optical aggregometry in assessing the efficacy of platelet membrane glycoprotein IIb/IIIa antagonists in vitro

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2007, De Gruyter

    Mojca Bozic

  27. Variation in Platelet Function Testing Has a Major Influence on Detection of Aspirin Resistance in Healthy Subjects

    Article • Pathophysiology of Haemostasis and Thrombosis, January 2007, Karger Publishers

    Mojca Bozic

  28. Low-grade haemostatic activation and increased fibrin turnover due to a retained central venous guide wire, found accidentally after eight years

    Article • Thrombosis and Haemostasis, January 2006, Thieme Publishing Group

    Mojca Bozic

  29. Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models

    Article • Thrombosis and Haemostasis, January 2005, Thieme Publishing Group

    Mojca Bozic

  30. Methyl-methacrylate bone cement surface does not promote platelet aggregation or plasma coagulation in vitro

    Article • Thrombosis Research, January 2004, Elsevier

    Mojca Bozic, Vivien Jiaqian Zhu 朱嘉倩

  31. Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors

    Article • Thrombosis and Haemostasis, January 2004, Thieme Publishing Group

    Mojca Bozic

  32. Factor V Leiden, prothrombin 20210G → A, methylenetetrahydrofolate reductase 677C → T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, December 2003, Elsevier

    Mojca Bozic

  33. Validation of an Automated Immunoturbidimetric Assay for Measurement of Plasma D-Dimer

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2003, De Gruyter

    Mojca Bozic

  34. Fibrinogen Polymorphisms Taq I, Hae III and Bcl I Are Not Associated with a Higher Risk of Deep Vein Thrombosis

    Article • Pathophysiology of Haemostasis and Thrombosis, January 2003, Karger Publishers

    Mojca Bozic

  35. Do Haemostasis Activation Markers that Predict Cardiovascular Disease Exist?

    Article • Pathophysiology of Haemostasis and Thrombosis, January 2003, Karger Publishers

    Mojca Bozic

  36. D-dimer, other markers of haemostasis activation and soluble adhesion molecules in patients with different clinical probabilities of deep vein thrombosis

    Article • Thrombosis Research, November 2002, Elsevier

    Mojca Bozic, Vivien Jiaqian Zhu 朱嘉倩

  37. Mild Hyperhomocysteinemia and Fibrinolytic Factors in Patients with History of Venous Thromboembolism

    Article • Thrombosis Research, November 2000, Elsevier

    Mojca Bozic